Procurement of Branded Drugs Under Price Negotiation Mechanism, Not Yet Resulted, for Medical Examination and Treatment Services in 2026 at Yen Bai Regional Medical Center

This tender is for the procurement of branded drugs that are subject to a price negotiation mechanism but have not yet yielded results. These drugs are intended to support medical examination and treatment services for the year 2026 at the Yen Bai Regional Medical Center. Identified by notification number IB2600064814, this procurement falls under the goods sector (HH) and is a contract award notification ('es-ct-contract'). The tender indicates a specific need for particular high-value or specialized medications where a standard bidding process might not be suitable or has proven insufficient. The price negotiation mechanism is employed to secure these essential medicines, ensuring their availability for patient care. The procurement aims to guarantee that the Yen Bai Regional Medical Center has access to the necessary treatments throughout 2026, thereby maintaining the quality and continuity of healthcare services provided to the local population. The focus on branded drugs suggests these are likely originator pharmaceuticals with specific therapeutic indications.

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Vietnam, Asia, this opportunity is open to firms and consortiums.

Published through Vietnam e-GP, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.